Page results
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
More than 8,000 people are waiting for a life-changing transplant and, sadly, donor and transplant numbers have fallen. This Organ Donation Week we want to make sure as many people as possible know how important their decision could be for people on the waiting list.
-
One of the FOIA Code of Practice requirements is for public authorities to publish more information about their performance in handling FOIA requests.
-
A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Colleagues, past and present, came together to mark the tenth anniversary of University College Hospital at Westmoreland Street.
-
This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.
-
A new service to provide comprehensive care and support for patients living with Sickle Cell disorder is now available in the comfort of their homes thanks to a partnership between UCLH and Whittington Health NHS Trusts.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
File results
-
FOI/2022/0393 - COVID-19 patient treatment between 16/03/2020 - 16/06/2020
-
FOI/2022/0399 - Staff networks at the Trust
-
FOI/2022/0402 - Breast Cancer patients (any stage) treatments
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0408 - Date UCLH became smoke-free
-
FOI/2022/0412 - Mental health inpatient facilities
-
FOI/2022/0413 - Head and neck cancer and urothelial cancer patients treatment and clinical trials
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0427 - Oesophageal and gastric cancer treatment
-
FOI/2022/0428 - Free parking for staff or patients